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This volume represents the proceedings of
a conference co-sponsored by the Epidemi-
ology Branch of the National Cancer In-
stitute and the National Foundation-March
of Dimes. Although the date of the con-
ference is not stated, some of the references
are as late as 1976. There are sections
dealing with relevant epidemiology, births,
defects and cancer, cytogenetics, single gene
disorders, cancer families, genetic markers,
cell hybridisation, DNA repair, theories and
future prospects.
The "cause" of common cancers is as
elusive as ever. Tumour immunology
remains extremely complex andconfusing and
the role of oncogenic viruses in man is
not yet clear. Nevertheless, there is an
impressivelistofachievementsinfundamental
cancer genetics, notably in cytogenetics, in
cell fusion studies and in progress in identi-
fying disorders of DNA repair. There are now
more than 40 rare cancers which are known to
have Mendelian inheritance (but in which
pathogenesis is often obscure) and an
increasing number of genetic markers appear
to be associated with cancer proneness or
resistance. The potential importance of
genetic marker studies is seen in ankylosing
spondylitis. If ankylosing spondylitis were a
curable cancer when diagnosed early, it
would probably be justified to HLA-B27
type all young males, since those positive
would have more than 100 times the risk of
those negative. The importance of cancer
registers is likely to increase as such genetic
markers become available. Scolnick describes
his work with the Mormons in which he is
"...trying to put together the genealogy of
the entire State of Utah ... (linked) to a
tumour registry ... so that the familial cases
can be studied in the context of other cancer
cases in the population". Total ascertainment
would largely eliminate the problem of
handling bias and if allied to genetic and
other marker studies and the computerised
recording of all known exposure to environ-
mental carcinogens, might well lead to a
clear understanding of the total accumula-
tion of cancer proneness which affects each of
us at various ages. However, there is much
discussion of and some distaste for the
concept of disease registers and many fear to
make easily available too much detailed
information about ourselves and our weak-
nesses. If reasonable confidentiality can be
guaranteed, as appears to be the case in
Utah, the next half century might well see
profitable computerisation ofmedical, genetic
and environmental data on a prospective
basis for the whole population. Events
separated in time and space affecting dif-
ferent members of the family would be put
into perspective, and the origins of common
cancers uncovered. Ultimately, the combina-
tion of computerised disease registers, genetic
markers and tests of fundamental sub-
cellular changes may greatly reduce the
cancer problem.
This volume will be of great interest to
everyone interested in cancer, since virtually
all aspects of the genetics and relevant
epidemiology are considered by a galaxy of
authors. The majority of articles are admir-
ably short with excellent bibliographies, and
this book represents a key acquisition for
libraries. Many clinicians and research
workers in the field will want a personal copy.
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The appearance of the second edition of
this book will be generally welcomed, since
being of encyclopaedic proportions, it aspires
to the status of a standard text-book,
bringing together a considerable diversity of
information between the same covers. It is
intended primarily for clinicians whose
concern is with the management ofmalignant
disease. As such it covers a wide area, from
the scientific foundations of tumour